Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients. - Trial NCT06252194
Access comprehensive clinical trial information for NCT06252194 through Pure Global AI's free database. This Phase 2 trial is sponsored by Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and is currently Recruiting. The study focuses on Acne Vulgaris. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Timeline & Enrollment
Phase 2
Mar 05, 2023
Mar 01, 2024
Primary Outcome
Global Acne Grading System (GAGS) Score
Summary
The goal of this clinical trial is to compare the effect of doxycycline and metformin in
 treatment of acne vulgaris patients. The main question is aimed to answer is whether
 metformin is more effective than doxycycline in treatment of acne vulgaris patient or not.
 
 Patients will be asked to take doxycycline along with tropical treatment in one group and
 metformin along with tropical treatment in another group.
 
 Researcher will compare the clinical improvement in two groups.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06252194
Non-Device Trial